Machine learning for prediction of cutaneous adverse events in patients receiving antiePD-1 immunotherapy

被引：11
|
作者：
Lewinson, Ryan T. [1 ,2 ]
Meyers, Daniel E. [3 ]
Vallerand, Isabelle A. [1 ]
Suo, Aleksi [3 ]
Dean, Michelle L. [3 ]
Cheng, Tina [3 ]
Bebb, Gwyn [3 ]
Morris, Don G. [3 ]
机构：
[1] Univ Calgary, Div Dermatol, Calgary, AB, Canada
[2] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada
[3] Univ Calgary, Dept Oncol, 1331 29th St NW, Calgary, AB T2N 4N2, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 84卷 / 01期
关键词：
D O I：
10.1016/j.jaad.2020.04.069
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：183 / 185
页数：3
相关论文
共 50 条
  • [1] Cutaneous side-effects during antiePD-1/antiePD-L1 therapy for lung cancer
    Rivera, Noelia
    Boada, Aram
    Bielsa, Isabel
    Carcereny, Enric
    Moran, Maria-Teresa
    Fernandez-Figueras, Maria-Teresa
    Posada, Rodolfo
    Ferrandiz, Carlos
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB96 - AB96
  • [2] Machine learning based prediction of serious adverse events in metastatic breast cancer patients receiving zoledronic acid
    Tanni, Kaniz Afroz
    Qian, Jingjing
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 568 - 568
  • [3] Prediction of major adverse clinical events in diabetic patients with machine learning
    Seah, J. Y. H.
    Xia, O. J. W.
    Low, L. L.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [4] PREDICTION OF BEST RESPONSE FOR NSCLC PATIENTS RECEIVING IMMUNOTHERAPY BY MACHINE LEARNING MODELS
    Zhang, Yili
    Gupta, Samir
    Belouali, Anas
    Lev-Ari, Shaked
    Shah, Neil
    Krishnamurthy, Kanchi
    Serzan, Micheal
    Alaoui, Adil
    McGarvey, Peter
    Atkins, Michael
    Madhavan, Subha
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1353 - A1353
  • [5] Sex differences in burden of adverse events in patients receiving immunotherapy
    Miceli, Rosalba
    Eriksson, Hanna
    Eustace, Alex J.
    Lo Russo, Giuseppe
    Alfieri, Salvatore
    Bjaanaes, Maria Moksnes
    Pietrantonio, Filippo
    De Cecco, Loris
    Prelaj, Arsela
    Proto, Claudia
    Franzen, Johan
    McDonnell, Deirdre
    Pina, Jose Javier Berenguer
    Beninato, Teresa
    Mazzeo, Laura
    Giannatempo, Patrizia
    Verzoni, Elena
    Crown, John
    Helland, Aslaug
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Explainable machine learning prediction of edema adverse events in patients treated with tepotinib
    Amato, Federico
    Strotmann, Rainer
    Castello, Roberto
    Bruns, Rolf
    Ghori, Vishal
    Johne, Andreas
    Berghoff, Karin
    Venkatakrishnan, Karthik
    Terranova, Nadia
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (09):
  • [7] Machine learning for prospective identification of immunotherapy related adverse events (irAEs).
    Margalski, Daniel
    Lycan, Thomas
    Rajendran, Suraj
    Topaloglu, Umit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach
    Heilbroner, Samuel Peter
    Few, Reed
    Mueller, Judith
    Chalwa, Jitesh
    Charest, Francois
    Suryadevara, Somasekhar
    Kratt, Christine
    Gomez-Caminero, Andres
    Dreyfus, Brian
    Neilan, Tomas G.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)
  • [9] Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: A machine learning approach.
    Dreyfus, Brian
    Heilbroner, Samuel P.
    Few, Reed
    Kratt, Christine
    Gomez, Andres
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Machine learning models for early prediction of potassium lowering effectiveness and adverse events in patients with hyperkalemia
    Huang, Wei
    Zhu, Jian-Yong
    Song, Cong-Ying
    Lu, Yuan-Qiang
    SCIENTIFIC REPORTS, 2024, 14 (01)
12345